Download presentation
Presentation is loading. Please wait.
Published byShanon Dawson Modified over 9 years ago
1
IgG4 Pancreatitis Dr Chan Lok Lam Laura United Christian Hospital JHSGR 6 th Aug, 2011
2
IgG4 pancreatitis Recently described disorder with protean manifestations Important diagnostic consideration in patients with obstructive jaundice associated with pancreatic mass lesion Mimics pancreatic cancer clinically and radiologically Dramatic response to steroid Correct diagnosis allows medical treatment and avoids major surgery
3
IgG4 pancreatitis = autoimmune pancreatitis? In previous literature YES! Concept evolving Autoimmune pancreatitis (AIP) Type I AIP (IgG4 pancreatitis)Pancreatic manifestation of systemic IgG4- related disease Type II AIP Specific pancreatic disease occasional association with ulcerative colitis
4
IgG4 pancreatitis Chronic inflammatory disease of presumed autoimmune origin Pathogenesis not well understood Lymphoplasmacytic infiltration with abundant IgG4 positive cells Inflammatory process responds well to steroid therapy
5
Epidemiology Uncommon 0.82 per 100,000 patients in a Japanese nationwide survey (2002) 4.6-6% in patients with chronic pancreatitis 3-5% undergoing pancreatic resection for suspected pancreatic cancer
6
Epidemiology Elderly Male
7
Extra-pancreatic manifestations Biliary strictures Sclerosing sialadenitis Retroperitoneal fibrosis Sclerosing cholecystitis Interstitial nephritis Diffuse lymphadenopathy Characteristic lymphoplasmacytic infiltrate rich in IgG4-positive cells Can precede/ accompany / follow pancreatic involvement
8
Clinical presentation Painless obstructive jaundice (65%) Vague abdominal pain Weight loss Exocrine insufficiency (88%) Endocrine dysfunction (67%)
9
Laboratory findings Amylase/ lipase: normal/ mildly elevated Gamma globulin, total IgG, IgG4 Commonly elevated Serum IgG4 : 140 mg/dl: Sensitivity 76%; Specificity 93% 280 mg/dl: Sensitivity 53%; Specificity 99% Elevated in 7-10% cases of Pancreatic CA (usually mild) Autoantibodies ANA, RF: elevated (non-specific)
10
Radiological CT/ MRI: Diffuse enlargement of the entire pancreas ‘sausage-like’ Low density capsule-like rim due to inflammation and fibrosis Delayed contrast enhancement
11
CT/ MRI Focally enlarged pancreas ‘inflammatory mass’
12
ERCP/ MRCP Diffuse narrowing of main pancreatic duct
13
ERCP/ MRCP Segmental narrowing of main pancreatic duct Biliary stricture ( can occur anywhere )
14
Differentiation IgG4 PancreatitisCA Pancreas Narrowing of MPD > 1/3 or > 3cm Pancreatic duct dilatation Skipped, narrow lesions of MPD Abrupt pancreatic duct cut- off Side branches from narrow portion of MPD Upstream pancreatic atrophy Stricture of intrahepatic ducts
15
EUS guided FNAC Detecting adenocarcinoma Sensitivity 70-90% Negative bx does not rule out CA Not for diagnosis of IgG4 pancreatitis Inadequate cells Lack of architecture
16
EUS guided core biopsy Allow diagnosis of IgG4 pancreatitis Technically difficult Increased risk of bleeding Not widely available
17
Biopsy of extra-pancreatic site Bile ducts, major duodenal papilla 80% pancreatic head involvement had IgG4-positive cells on biopsy of the major duodenal papilla
18
Response to steroid Dramatic
19
Response to steroid Radiographic response seen at 2-3 wks and normalization at 4-6 wks
20
Response to steroid Steroid trial controversial No response within 2 weeks makes IgG4 pancreatitis unlikely Failed response to steroid Prompt re-evaluation of diagnosis Consider surgery to look for cancer
21
Making the correct diagnosis is challenging Rare disease Mimic the more common pancreaticobiliary malignancy No single diagnostic test available Price of misdiagnosis is heavy Unnecessary surgery for benign disease Delay potentially curative surgery
22
Japanese Diagnostic Criteria 1. Imaging - Diffuse/ segmental narrowing of main pancreatic duct - Diffuse/ localized enlargement of pancreas 2. Serology - Elevated gamma-globulin, IgG or IgG4 OR - Presence of autoantibodies eg ANA/ RF 3. Histology - Lymphoplasmacytic sclerosing pancreatitis Diagnosis: 1 + 2/3
23
Take Home Message Increasing recognition Important diagnostic consideration in obstructive jaundice due to pancreatic mass lesion High index of suspicion Multidisciplinary collaboration Surgeons/GI physician/Radiologist/Pathologist
24
The END
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.